Sudeep Pharma Share Price Surges 24% on Listing Day

Sudeep Pharma IPO opened for subscription on Nov 21, 2025, and ended on Nov 25, 2025. 

Sudeep Pharma’s IPO is a book-building issue worth ₹895.00 crore, comprising a fresh issue of 0.16 crore shares totaling ₹95.00 crore and an offer for sale of 1.35 crore shares amounting to ₹800.00 crore.

Sudeep Pharma’s IPO was subscribed 93.71 times overall. As of November 25, 2025, 6:19:33 PM (Day 3), the public issue saw subscription of 15.65 times in the retail segment, 213.08 times in the QIB (excluding anchor investors) category, and 116.72 times in the NII segment.

The share allotment was finalised on Nov 26, 2025, and the shares were listed on BSE and NSE on Friday, Nov 28, 2025.

Sudeep Pharma Share Price

On the listing day, on the NSE, Sudeep Pharma share price (NSE: SUDEEPPHRM) opened at ₹730.00, up from its issue price of ₹593.00. At 10:08 AM, the share price was trading at ₹738.00, up by 1.10% from its open price and up by 24.18% from its issue price. As of the same time, the stock touched its day’s high at ₹741.00. The company’s market cap was ₹8,314.15 crore. 

On the BSE, at 10:10 AM, Sudeep Pharma share price was trading at ₹737.50, up by 0.48% from its opening price of ₹733.95 and 24.37% up from its issue price of ₹593.00.

About Sudeep Pharma Limited

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients, serving clients in over 100 countries. 

The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specialising in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium, and supplies more than 200 products across the pharmaceutical, food, and nutrition sectors. 

Sudeep Pharma also has R&D capabilities, with in-house laboratories and pilot-scale facilities focused on mineral salts and excipients. Its product portfolio includes the Pharmaceutical, Food and Nutrition Business, Specialty Ingredients Business, and Triturates. 

As of December 31, 2024, the company had 704 permanent employees.

Also Read: Jio Platforms May Be Valued Up to US$170 Billion Ahead of IPO!

Conclusion

Sudeep Pharma share price surged on listing, reflecting market demand and investor confidence in the stock.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.